A detailed history of Td Asset Management Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 38,130 shares of MDGL stock, worth $12.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
38,130
Previous 55,730 31.58%
Holding current value
$12.7 Million
Previous $15.6 Million 48.18%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$212.22 - $292.96 $3.74 Million - $5.16 Million
-17,600 Reduced 31.58%
38,130 $8.09 Million
Q2 2024

Aug 02, 2024

BUY
$193.33 - $291.99 $1.04 Million - $1.58 Million
5,400 Added 10.73%
55,730 $15.6 Million
Q1 2024

May 08, 2024

BUY
$171.37 - $283.23 $5.96 Million - $9.85 Million
34,790 Added 223.87%
50,330 $13.4 Million
Q4 2023

Feb 12, 2024

BUY
$120.4 - $237.13 $1.87 Million - $3.69 Million
15,540 New
15,540 $3.6 Million
Q1 2021

May 14, 2021

SELL
$108.54 - $125.2 $520,992 - $600,960
-4,800 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$99.78 - $124.21 $159,149 - $198,114
1,595 Added 49.77%
4,800 $570,000
Q2 2020

Aug 13, 2020

BUY
$60.13 - $125.71 $192,716 - $402,900
3,205 New
3,205 $363,000
Q3 2019

Nov 07, 2019

SELL
$84.4 - $106.53 $505,387 - $637,901
-5,988 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$91.13 - $142.5 $9,113 - $14,250
100 Added 1.7%
5,988 $628,000
Q1 2019

May 08, 2019

SELL
$103.48 - $143.84 $62,088 - $86,304
-600 Reduced 9.25%
5,888 $738,000
Q4 2018

Feb 01, 2019

SELL
$94.77 - $215.54 $654,292 - $1.49 Million
-6,904 Reduced 51.55%
6,488 $731,000
Q3 2018

Nov 01, 2018

SELL
$207.3 - $300.31 $706,478 - $1.02 Million
-3,408 Reduced 20.29%
13,392 $2.87 Million
Q2 2018

Jul 31, 2018

BUY
$101.55 - $313.9 $873,330 - $2.7 Million
8,600 Added 104.88%
16,800 $4.7 Million
Q1 2018

May 11, 2018

BUY
$93.35 - $149.04 $765,470 - $1.22 Million
8,200 New
8,200 $958,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.69B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.